Estrogen-mediated mechanisms in estrogen receptor-positive breast cancer at the single cell level

被引：1
|
作者：
Mori, Hitomi
Saeki, Kohei
Chang, Gregory
Wang, Jinhui
Wu, Xiwei
Hsu, Pei-Yin
Kanaya, Noriko
Somlo, George
Nakamura, Masafumi
Bild, Andrea
Chen, Shiuan
机构：
来源：
CANCER RESEARCH | 2022年 / 82卷 / 04期
关键词：
D O I：
10.1158/1538-7445.SABCS21-PD1-04
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PD1-04
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Treatment strategy for metastatic breast cancer with estrogen receptor-positive tumor
    Iwase, Hirotaka
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2015, 20 (02) : 249 - 252
  • [42] Response of Estrogen Receptor-Positive Breast Cancer Tumorspheres to Antiestrogen Treatments
    Ao, Ada
    Morrison, Brian J.
    Wang, Heiman
    Lopez, J. Alejandro
    Reynolds, Brent A.
    Lu, Jianrong
    PLOS ONE, 2011, 6 (04):
  • [43] Treatment strategy for metastatic breast cancer with estrogen receptor-positive tumor
    Iwase, Hirotaka
    ANNALS OF ONCOLOGY, 2017, 28 : 27 - 27
  • [44] Synaptotagmin 13 Is Highly Expressed in Estrogen Receptor-Positive Breast Cancer
    Ichikawa, Takahiro
    Shibata, Masahiro
    Inaishi, Takahiro
    Soeda, Ikumi
    Kanda, Mitsuro
    Hayashi, Masamichi
    Takano, Yuko
    Takeuchi, Dai
    Tsunoda, Nobuyuki
    Kodera, Yasuhiro
    Kikumori, Toyone
    CURRENT ONCOLOGY, 2021, 28 (05) : 4080 - 4092
  • [45] Factors Predicting Late Recurrence for Estrogen Receptor-Positive Breast Cancer
    Sestak, Ivana
    Dowsett, Mitch
    Zabaglo, Lila
    Lopez-Knowles, Elena
    Ferree, Sean
    Cowens, J. Wayne
    Cuzick, Jack
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2013, 105 (19): : 1504 - 1511
  • [46] Complete estrogen blockade in advanced postmenopausal receptor-positive breast cancer
    Nature Clinical Practice Oncology, 2008, 5 (2): : 67 - 67
  • [47] Neoadjuvant endocrine therapy for estrogen receptor-positive primary breast cancer
    Yamamoto, Yutaka
    Goto-Yamaguchi, Lisa
    Takeno, Masako
    Yamamoto-Ibusuki, Mutsuko
    CHINESE CLINICAL ONCOLOGY, 2020, 9 (03) : 30
  • [48] What is the role of chemotherapy in estrogen receptor-positive, advanced breast cancer?
    Barrios, C. H.
    Sampaio, C.
    Vinholes, J.
    Caponero, R.
    ANNALS OF ONCOLOGY, 2009, 20 (07) : 1157 - 1162
  • [49] Safety of everolimus in estrogen receptor-positive advanced breast cancer.
    Perez, Alejandra T.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (27)
  • [50] Fulvestrant radiosensitizes human estrogen receptor-positive breast cancer cells
    Wang, Jing
    Yang, Qifeng
    Haffty, Bruce G.
    Li, Xiaoyan
    Moran, Meena S.
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2013, 431 (02) : 146 - 151
12345